Dermatologists Embrace Low-Dose Oral Minoxidil for Hair Loss
The inexpensive medication is safe and has relatively few drawbacks, say dermatologists.
Source: medscape.com
📰 Adjuvant News
Page 4 - Adjuvant News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Adjuvant. Real-time updates on events, politics, business and more.
Merck: KEYTRUDA Approved In Canada For Adjuvant Treatment Of Patients With Stage IIB Or IIC Melanoma
KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) announced that Health Canada has granted approval for KEYTRUDA, the company's anti-PD-1 therapy, for the adjuvant treatment of adult and pediatric patients
Source: finanznachrichten.de
MegaPro Successfully Completes the biological evaluations of IOP as Vaccine Adjuvant T cell mediated Immunity is Substantially Enhanced, Improving the Efficacy of Vaccines
DJ MegaPro Successfully Completes the biological evaluations of IOP as Vaccine Adjuvant T cell mediated Immunity is Substantially Enhanced, Improving the Efficacy of Vaccines EQS Newswire / 26/07/2022
Kostenloser Wertpapierhandel Jassy Wang Vaccine Adjuvant Cell Experiment Press Financial Press Megapro Biomedical Co Ltd Pro Successfully Completes
Source: finanznachrichten.de
Study shows that selection of breast cancer patients for adjuvant bisphosphonate therapy based on Inbiomotion's MAFTEST reduces the risk of death in comparison with current clinical guidance
MAFTEST analyses of the NSABP-B34 and AZURE landmark clinical trials confirmed clinical utility of the MAFTEST for selection of early-stage breast cancer patients that benefit from adjuvant
Comunidad Autonoma De Cataluna United Kingdom Rogerr Gomis Robert Coleman Roger Gomis Alexander Hg Paterson
Source: finanznachrichten.de
Clinical Challenges: Test Your Knowledge About Advances in RCC
A three-part quiz on surgery, adjuvant therapy, and first-line options in metastatic disease
Source: medpagetoday.com
Clinical Challenges: Use of Adjuvant Immunotherapy in RCC
More data awaited, but until then, decisions should be made on case-by-case basis
United States University Of Pennsylvania Naomi Haas Leah Lawrence Rana Mckay University Of California San Diego
Source: medpagetoday.com
Tumor DNA Assay Portends Metastatic Breast Cancer Recurrence Months in Advance
First evidence for patients in late adjuvant setting, years after initial diagnosis
United States University Of Pennsylvania Dana Farber Cancer Institute Angela Demichele Heathera Parsons Charles Bankhead
Source: medpagetoday.com
F. Hoffmann-La Roche Ltd: European Commission approves Roche's Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer
In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resected Stage II-III NSCLC, compared with best supportive careTecentriq
United Kingdom United States Israel General Comunidad Autonoma De Cataluna Nathalie Meetz Levi Garraway
Source: finanznachrichten.de
Roche's Tecentriq Gets EC Nod As Adjuvant Treatment For Certain People With Early-stage NSCLC
SOUTH SAN FRANCISCO (dpa-AFX) - Roche Holding AG's (RHHBY) blockbuster drug Tecentriq has been approved by the European Commission for yet another lung cancer indication - this time, as an adjuvant
United Kingdom Levi Garraway European Commission Head Of Global Product Development Roche Holding Chief Medical Officer
Source: finanznachrichten.de
Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma
First study conducted in the adjuvant setting with a combination of BRAF and MEK inhibitors in high-risk stage II BRAF V600E/K-mutant cutaneous melanomaA global partnership between EORTC and
Source: finanznachrichten.de